William R. Macon

8.1k total citations
139 papers, 4.9k citations indexed

About

William R. Macon is a scholar working on Pathology and Forensic Medicine, Oncology and Genetics. According to data from OpenAlex, William R. Macon has authored 139 papers receiving a total of 4.9k indexed citations (citations by other indexed papers that have themselves been cited), including 109 papers in Pathology and Forensic Medicine, 58 papers in Oncology and 48 papers in Genetics. Recurrent topics in William R. Macon's work include Lymphoma Diagnosis and Treatment (105 papers), Chronic Lymphocytic Leukemia Research (44 papers) and Viral-associated cancers and disorders (36 papers). William R. Macon is often cited by papers focused on Lymphoma Diagnosis and Treatment (105 papers), Chronic Lymphocytic Leukemia Research (44 papers) and Viral-associated cancers and disorders (36 papers). William R. Macon collaborates with scholars based in United States, Italy and Canada. William R. Macon's co-authors include Thomas M. Habermann, Thomas E. Witzig, Stephen M. Ansell, Matthew J. Maurer, James R. Cerhan, Grzegorz S. Nowakowski, David J. Inwards, Paul J. Kurtin, Susan L. Slager and Andrew L. Feldman and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

William R. Macon

133 papers receiving 4.8k citations

Peers

Countries citing papers authored by William R. Macon

Since Specialization

Citations

This map shows the geographic impact of William R. Macon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by William R. Macon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites William R. Macon more than expected).

Fields of papers citing papers by William R. Macon

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by William R. Macon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by William R. Macon. The network helps show where William R. Macon may publish in the future.

Co-authorship network of co-authors of William R. Macon

This figure shows the co-authorship network connecting the top 25 collaborators of William R. Macon. A scholar is included among the top collaborators of William R. Macon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with William R. Macon. William R. Macon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	PET2 response associated with survival in newly diagnosed diffuse large B-cell lymphoma: results of two independent prospective cohorts 2022 ·Blood Cancer Journal ·(unknown), Levi Pederson, Betsy LaPlant, Raphael Mwangi, Matthew J. Maurer, Jason R. Young, William R. Macon, Rebecca L. King, Yucai Wang, James R. Cerhan, Andrew L. Feldman, David J. Inwards, Ivana N. Micallef, Patrick B. Johnston, Luis F. Porrata, Stephen M. Ansell, Thomas M. Habermann, Thomas E. Witzig, Grzegorz S. Nowakowski	5
2	Aspirin and other nonsteroidal anti‐inflammatory drugs, statins and risk of non‐Hodgkin lymphoma 2021 ·International Journal of Cancer ·Mark Liebow, Melissa C. Larson, Carrie A. Thompson, Grzegorz S. Nowakowski, Timothy G. Call, William R. Macon, Neil E. Kay, Thomas M. Habermann, Susan L. Slager, James R. Cerhan	7
3	Patterns of therapy initiation during the first decade for patients with follicular lymphoma who were observed at diagnosis in the rituximab era 2021 ·Blood Cancer Journal ·Arushi Khurana, Raphael Mwangi, Stephen M. Ansell, Thomas M. Habermann, James R. Cerhan, Christopher Strouse, Brian K. Link, Yucai Wang, Rebecca L. King, William R. Macon, José C. Villasboas, Thomas E. Witzig, Matthew J. Maurer, Grzegorz S. Nowakowski	6
4	Cutaneous ALK-positive histiocytosis 2021 ·Journal of Hematopathology ·Michael Keeney, Thomas J. Flotte, William R. Macon	1
5	Lenalidomide in combination with R-CHOP produces high response rates and progression-free survival in new, untreated diffuse large B-cell lymphoma transformed from follicular lymphoma: results from the Phase 2 MC078E study 2021 ·Blood Cancer Journal ·(unknown), Betsy LaPlant, William R. Macon, Rebecca L. King, Yucai Wang, David J. Inwards, Ivana N. Micallef, Patrick B. Johnston, Luis F. Porrata, Stephen M. Ansell, Thomas M. Habermann, Thomas E. Witzig, Grzegorz S. Nowakowski	7
6	Assessing for disease: recurrent mycosis fungoides or cutaneous granulomatous drug eruption after mogamulizumab therapy 2020 ·Journal of Hematopathology ·(unknown), Alina G. Bridges, William R. Macon	1
7	Elucidating a false-negative MYC break-apart fluorescence in situ hybridization probe study by next-generation sequencing in a patient with high-grade B-cell lymphoma with IGH/MYC and IGH/BCL2 rearrangements 2019 ·Molecular Case Studies ·Jess F. Peterson, Beth A. Pitel, Stephanie A. Smoley, George Vasmatzis, James B. Smadbeck, Patricia T. Greipp, Rhett P. Ketterling, William R. Macon, Linda B. Baughn	15
8	High-grade B-cell lymphoma with MYC and BCL2 and/or BCL6 rearrangements with diffuse large B-cell lymphoma morphology 2018 ·Blood ·David W. Scott, Rebecca L. King, Annette M. Staiger, Susana Ben‐Neriah, Aixiang Jiang, Heike Horn, Anja Mottok, Pedro Farinha, Graham W. Slack, Daisuke Ennishi, Norbert Schmitz, Michael Pfreundschuh, Grzegorz S. Nowakowski, Brad S. Kahl, Joseph M. Connors, Randy D. Gascoyne, German Ott, William R. Macon, Andreas Rosenwald	145
9	The mTORC1 inhibitor everolimus has antitumor activity in vitro and produces tumor responses in patients with relapsed T-cell lymphoma 2015 ·Blood ·Thomas E. Witzig, Craig B. Reeder, Jing Han, Betsy LaPlant, Mary Stenson, Han W. Tun, William R. Macon, Stephen M. Ansell, Thomas M. Habermann, David J. Inwards, Ivana N. Micallef, Patrick B. Johnston, Luis F. Porrata, Joseph P. Colgan, Svetomir N. Markovic, Grzegorz S. Nowakowski, Mamta Gupta	83
10	Lenalidomide Combined With R-CHOP Overcomes Negative Prognostic Impact of Non–Germinal Center B-Cell Phenotype in Newly Diagnosed Diffuse Large B-Cell Lymphoma: A Phase II Study 2014 ·Journal of Clinical Oncology ·Grzegorz S. Nowakowski, Betsy LaPlant, William R. Macon, Craig B. Reeder, James M. Foran, Garth D. Nelson, Carrie A. Thompson, Candido E. Rivera, David J. Inwards, Ivana N. Micallef, Patrick B. Johnston, Luis F. Porrata, Stephen M. Ansell, Randy D. Gascoyne, Thomas M. Habermann, Thomas E. Witzig	268
11	Early life sun exposure, vitamin D-related gene variants, and risk of non-Hodgkin lymphoma 2012 ·Cancer Causes & Control ·Jennifer L. Kelly, Matthew T. Drake, Zachary S. Fredericksen, Yan W. Asmann, Mark Liebow, Tait D. Shanafelt, Andrew L. Feldman, Stephen M. Ansell, William R. Macon, Megan M. Herr, Alice H. Wang, Grzegorz S. Nowakowski, Timothy G. Call, Thomas M. Habermann, Susan L. Slager, Thomas E. Witzig, James R. Cerhan	35
12	The association between early life and adult body mass index and physical activity with risk of non-Hodgkin lymphoma: impact of gender 2012 ·Annals of Epidemiology ·Jennifer L. Kelly, Zachary S. Fredericksen, Mark Liebow, Tait D. Shanafelt, Carrie A. Thompson, Timothy G. Call, Thomas M. Habermann, William R. Macon, Alice H. Wang, Susan L. Slager, James R. Cerhan	16
13	Food‐frequency questionnaire‐based estimates of total antioxidant capacity and risk of non‐Hodgkin lymphoma 2011 ·International Journal of Cancer ·Shernan G. Holtan, Helen M. O’Connor, Zachary S. Fredericksen, Mark Liebow, Carrie A. Thompson, William R. Macon, Ivana N. Micallef, Alice H. Wang, Susan L. Slager, Thomas M. Habermann, Timothy G. Call, James R. Cerhan	36
14	Elevated serum free light chains are associated with inferior event free and overall survival in Hodgkin lymphoma 2011 ·American Journal of Hematology ·Carrie A. Thompson, Matthew J. Maurer, James R. Cerhan, Jerry A. Katzmann, Stephen M. Ansell, Thomas M. Habermann, William R. Macon, George J. Weiner, Brian K. Link, Thomas E. Witzig	20
15	Expression of p21 Protein Predicts Clinical Outcome in DLBCL Patients Older than 60 Years Treated with R-CHOP but not CHOP: A Prospective ECOG and Southwest Oncology Group Correlative Study on E4494 2010 ·Clinical Cancer Research ·Jane N. Winter, Shuli Li, (unknown), Daina Variakojis, Beverly P. Nelson, Maryla Krajewska, Lijun Zhang, Thomas M. Habermann, Richard I. Fisher, William R. Macon, Mukesh Chhanabhai, Raymond E. Felgar, Eric D. Hsi, L. Jeffrey Medeiros, James K. Weick, Edie Weller, Ari Melnick, John C. Reed, Sandra J. Horning, Randy D. Gascoyne	26
16	Statin Use and Prognosis in Patients With Diffuse Large B-Cell Lymphoma and Follicular Lymphoma in the Rituximab Era 2009 ·Journal of Clinical Oncology ·Grzegorz S. Nowakowski, Matthew J. Maurer, Thomas M. Habermann, Stephen M. Ansell, William R. Macon, Kay M. Ristow, Cristine Allmer, Susan L. Slager, Thomas E. Witzig, James R. Cerhan	45
17	Overexpression of Syk tyrosine kinase in peripheral T-cell lymphomas 2008 ·Leukemia ·Andrew L. Feldman, (unknown), Mark E. Law, Anne J. Novak, Ayoma D. Attygalle, Erik C. Thorland, Stephanie Fink, Julie A. Vrana, Bolette L. Caron, William G. Morice, Ellen D. Remstein, Karen L. Grogg, Paul J. Kurtin, William R. Macon, Ahmet Doǧan	107
18	Primary cardiac plasmablastic (diffuse large B-cell) lymphoma mimicking left ventricular aneurysm with mural thrombus 2007 ·Cardiovascular Pathology ·Dylan V. Miller, Farouk Mookadam, Martina Mookadam, William D. Edwards, William R. Macon	20
19	Hepatosplenic ɑß T-Cell Lymphomas 2001 ·The American Journal of Surgical Pathology ·William R. Macon, Nicolas Lévy, Paul J. Kurtin, Kevin E. Salhany, (unknown), Terence T. Casey, Fiona E. Craig, Cindy L. Vnencak‐Jones, Margaret L. Gulley, Jonathan P. Park, John B. Cousar	133
20	Large-cell lymphomas: clinical and prognostic features. 1990 ·Journal of Clinical Oncology ·R S Stein, J P Greer, John M. Flexner, John D. Hainsworth, Robert D. Collins, William R. Macon, John B. Cousar	28

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact